MWN109 3

DRUG6 trials

Sponsors

Shanghai Minwei Biotechnology Co., Ltd

Conditions

Overweight , ObesityType 2 Diabetes Mellitus (T2DM)

Phase 1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

CompletedNCT07787728

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2025-07-14End: 2025-12-16Updated: 2026-08-28

Phase 2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

CompletedNCT07791524

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2026-01-05End: 2026-07-09Updated: 2026-08-28

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

CompletedNCT07791654

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2025-08-23End: 2026-03-21Updated: 2026-08-28

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

Active, not recruitingNCT07791537

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2025-12-26End: 2026-11-01Updated: 2026-08-28

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus

RecruitingNCT07801820

Shanghai Minwei Biotechnology Co., LtdType 2 Diabetes Mellitus (T2DM)

Start: 2026-06-23End: 2027-03-01Target: 240Updated: 2026-09-09

Phase 3

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

Not yet recruitingNCT07778693

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2026-09-01End: 2027-11-01Target: 760Updated: 2026-08-21